Canada eyeing implications of U.S. plan to allow imports of prescription drugs

Canada’s drug supply is simply not sufficient to support both Canada and U.S. markets, organizations say

Canada eyeing implications of U.S. plan to allow imports of prescription drugs

Canada’s health minister says the federal government is in touch with U.S. officials to discuss the Trump administration’s plan to allow imports of cheaper prescription drugs from north of the border.

In a statement, officials for Ginette Petitpas Taylor are describing the latest display of American interest in Canadian medication as further evidence of Canada’s commitment to more affordable prescription drugs.

The statement says Ottawa is constantly monitoring the Canadian drug supply, and will work closely with health experts to better understand the implications for Canadians and avoid any adverse effects on supply or drug costs.

The U.S. administration announced today it intends to set up a system that would allow Americans to legally import lower-cost prescription drugs from Canada.

READ MORE: U.S. to set up plan allowing prescription drugs from Canada

A recent spike in U.S. interest in cheaper Canadian medication — it has become a central issue in the American election campaign — prompted more than a dozen organizations to urge Petitpas Taylor to safeguard the Canadian supply.

In a letter, the groups say Canada’s drug supply is simply not sufficient to support both the Canadian and the U.S. market.

The Canadian Press

Like us on Facebook and follow us on Twitter.

Be Among The First To Know

Sign up for a free account today, and receive top headlines in your inbox Monday to Saturday.

Sign Up with google Sign Up with facebook

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Reset your password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A link has been emailed to you - check your inbox.



Don't have an account? Click here to sign up